The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection

Journal of Hepatology

Volumn 47, Issue 5, 2007, Pages 632-641

  Larrubia, Juan Ramón ^a   Calvino, Miryam ^a   Benito, Selma ^a   Sanz de Villalobos, Eduardo ^a   Perna, Cristian ^a   Pérez Hornedo, Jaime ^a   González Mateos, Fernando ^a   García Garzón, Silvia ^a   Bienvenido, Antonio ^a   Parra, Trinidad ^a  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

Author keywords

CCL3; CCR5; Chemokine receptors; Chemokines; Chemotaxis; CXCL10; CXCR3; Hepatitis C virus; Liver damage; Viral escape mechanism

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; ARTICLE; BLOOD; BLOOD LEVEL; CD8+ T LYMPHOCYTE; CHEMOTAXIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LIVER INJURY; LYMPHOCYTE; MALE; OUTCOME ASSESSMENT; PERSISTENT INFECTION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; CELL DEATH; CHEMOKINE CCL3; CHEMOKINE CXCL10; CHRONIC DISEASE; CYTOKINES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; LIVER; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, CCR5; RECEPTORS, CXCR3; T-LYMPHOCYTES, CYTOTOXIC; UP-REGULATION;

EID: 34848852233     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.04.009     Document Type: Article

References (44)

1. Lauer G.M., and Walker B.D. Hepatitis C virus infection. N Eng J Med 345 (2001) 41-52
2. Guidotti L.G., and Chisari V. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol Mech Dis 1 (2006) 23-61
3. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Eng J Med 354 (2006) 610-621
4. Bonecchi R., Bianchi G., Bordignon P.P., D'Ambrosio D., Lang R., Borsatti A., et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper (Th1s) and Th2s. J Exp Med 187 (1998) 129-134
5. Qin S., Rottman J.B., Myers P., Kassam N., Weinblatt M., Loetscher M., et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 101 (1998) 746-754
6. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today 20 (1999) 254-257
7. Nansen A., Christensen J.P., Andreasen S.O., Bartholdy C., Christensen J.E., and Thomsen A.R. The role of CC chemokine receptor 5 in antiviral immunity. Blood 99 (2002) 1237-1245
8. Loetscher P., Uguccioni M., Bordoli L., Baggiolini M., Moser B., Chizzolini C., et al. CCR5 is characteristic of Th1 lymphocytes. Nature 391 (1998) 344-345
9. Cerwenka A., Morgan T.M., Harmsen A.G., and Dutton R.W. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J Exp Med 189 (1999) 423-434
10. Murai M., Yoneyama H., Harada A., Yi Z., Vestergaard C., Guo B., et al. Active participation of CCR5(+) CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest 104 (1999) 49-57
11. Manns M.P., McHutchinson J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358 (2001) 958-965
12. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Gonçales Jr. F.L., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Eng J Med 347 (2002) 975-982
13. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C 2002. Gastroenterology 2002;123:2082-2099.
14. Maini M.K., Boni C., Lee C.K., Larrubia J.R., Reignat S., Ogg G.S., et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 191 (2000) 1269-1280
15. Costantini A., Mancini S., Giuliodoro S., Butini L., Regnery C.M., Silvestrini G., et al. Effects of cryopreservation on lymphocyte immunophenotype and function. J Immunol Methods 278 (2003) 145-155
16. Wang J., Holmes T.H., Cheung R., Greenberg H.B., and He X.S. Expression of chemokine receptors on intrahepatic and peripheral lymphocytes in chronic hepatitis C infection: its relationship to liver inflammation. J Infect Dis 190 (2004) 989-997
17. Speiser D.E., Pittet M.J., Valmori D., Dunbar R., Rimoldi D., Liénard D., et al. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J Exp Med 190 (1999) 775-782
18. Horvatinovich J.M., Sparks S.D., and Mann K.P. Establishing a pure lymphocyte gate for subset analysis by flow cytometry. Cytometry 26 (1996) 172-177
19. Scheuer P.J. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13 (1991) 372-374
20. Shields P.L., Morland C.M., Salmon M., Qin S., Hubscher S.G., and Adams D.H. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 163 (1999) 6236-6243
21. Dianhua J., Jiurong L., Jennifer H., Bao L., Zhou Z., Shuang Y., et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest 114 (2004) 291-299
22. Apolinario A., Majano P.L., Alvarez-Perez E., Saez A., Lozano C., Vargas J., et al. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with histological activity of liver disease. Am J Gastroenterol 97 (2002) 2861-2870
23. + T cell differentiation and bridges central and peripheral functions. J Immunol 171 (2003) 2812-2824
24. Sprengers D., van der Molen R.G., Kusters J.G., Kwekkeboom J., van der Laan L.J., Niesters H.G., et al. Flow cytometry of fine-needle-aspiration biopsies: a new method to monitor the intrahepatic immunological environment in chronic viral hepatitis. J Viral Hepat 12 (2005) 507-512
25. Leroy V., Mosnier J.F., Dufeu-Duchesne T., Pernollet M., Zarski J.P., Marche P.N., et al. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology 38 (2003) 829-841
26. Bertoletti A., and Maini M.K. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?. Curr Opin Immunol 12 (2000) 403-408
27. Patzwahl R., Meier V., Ramadori G., and Mihm S. Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization. J Virol 75 (2001) 1332-1338
28. Kusano F., Tanaka Y., Marumo F., and Sato C. Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Lab Invest 80 (2000) 415-422
29. Helbig K.J., Ruszkiewicz A., Semendric L., Harley H.A., McColl S.R., and Beard M.R. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology 39 (2004) 1220-1229
30. Harvey C.E., Post J.J., Palladinetti P., Freeman A.J., French R.A., Kumar R.K., et al. Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J Leukoc Biol 74 (2003) 360-369
31. Alter H.J. HCV natural history: the retrospective and prospective in perspective. J Hepatol 43 (2005) 550-552
32. Gruener N.H., Lechner F., Jung M.C., Diepolder H., Gerlach T., Lauer G., et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 75 (2001) 5550-5558
33. Lichterfeld M., Leifeld L., Nischalke H.D., Rockstroh J.K., Hess L., Sauerbruch T., et al. Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection. J Infect Dis 185 (2002) 1803-1807
34. Linnen J., Wages Jr. J., Zhang-Keck Z.Y., Fry K.E., Krawczynski K.Z., Alter H., et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271 (1996) 505-508
35. Natterman J., Nishalke H.D., Kupfer B., Rockstroh J., Hess L., Sauerbruch T., et al. Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS 17 (2003) 1457-1462
36. Xiang J., George S.L., Wünschmann S., Chang Q., Klinzman D., and Stapleton J.T. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1α, MIP-1β and SDF-1. Lancet 363 (2004) 2040-2046
37. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., et al. Binding of hepatitis C virus to CD81. Science 282 (1998) 938-941
38. Nattermann J., Nishallke H.D., Feldmann G., Ahlenstiel G., Sauerbruch T., and Spengler U. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5. J Viral Hepat 11 (2004) 519-526
39. Apolinaro A., Manjano P.L., Lorente R., Nunez O., Clemente G., and Garcia-Monzon C. Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins. J Viral Hepat 12 (2005) 27-37
40. Yang Y.F., Tomura M., Iwasaki M., Ono S., Zou J.P., Uno K., et al. IFN-α acts on T-cell receptor-triggered human peripheral leukocytes to up-regulate CCR5 expression on CD4+ and CD8+ T cells. J Clin Immunol 21 (2001) 402-409
41. Butera D., Marukian S., Iwamaye A.E., Hembrador E., Chambers T.J., Di Bisceglie A.M., et al. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood 106 (2005) 1175-1182
42. Yamauchi K., Akbar S.M., Horiike N., Michitaka K., and Onji M. Increased serum levels of macrophage inflammatory protein-3alpha in chronic viral hepatitis: prognostic importance of macrophage inflammatory protein-3alpha during interferon therapy in chronic hepatitis C. J Viral Hepat 9 (2002) 213-220
43. Lagging M., Romero A.I., Westin J., Norkrans G., Dhillon A.P., Pawlotsky J.M., et al. IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology 44 (2006) 1617-1625
44. Diago M., Castellano G., García-Samaniego J., Pérez C., Fernández I., Romero M., et al. Association of pre-treatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut 55 (2006) 374-379